The present invention relates to a dosage form comprising functionalized calcium carbonate serving as active ingredient. The invention further relates to the use of the dosage form as nutritional supplement or as a medicament and to the use of functionalized calcium carbonate as active ingredient, preferably in the field of calcium fortification and in the treatment of calcium deficiency.

Provided is a composition comprising a) butyrate and b) a by-product of fermentation of a carbon source-containing feedstock with a Clostridia class bacterium which natively produces butyric acid. Further provided are a feed ingredient, an animal feed and an anti-icing product comprising the composition, methods of manufacturing and uses thereof.

A method of improving microbiome within an animal can comprise administering to the animal a composition comprising a probiotic and psyllium, wherein the probiotic comprises at least one of any suitable strain or subspecies of Enterococcus. Compositions containing a probiotic and psyllium are also provided herein.

The present disclosure encompasses a non-caking, free-flowing composition comprising choline chloride.

The present disclosure relates to metal di-amino acid chelates and metal tri-amino acid chelates.

Methods and compositions are described for producing a phytase in transgenic maize plants and then incorporating parts of the transgenic maize plants in animal feed. The feed phytase enzyme displays activity across a broad pH range, and tolerance to temperatures that are often encountered during the process of preparing animal feeds. Methods of producing an animal feed that incorporate the transgenic maize plants, parts thereof or plant derived phytases, as well as methods of promoting the release of inorganic phosphate from a phytic acid in an animal, producing an animal meat, or reducing the ratio of intake of an animal feed per weight of the animal meat by feeding an animal with the animal feed incorporating transgenic maize plants are provided.

The present invention relates to a feed composition using perilla meal, in which the ratio of omega-3 (omega-3) fatty acid and omega-6 (omega-6) fatty acid is adjusted to 1:4 or less to obtain livestock products, such as meat or milk, containing a large amount of unsaturated fatty acid. More specifically, the present invention related to a feed composition using perilla meal to produce livestock products with the ratio of omega-3 to omega-6 fatty acids being 1:4 or less which is a recommended ratio of the World Health Organization (WHO).

The present invention relates to a feed composition using perilla meal, in which the ratio of omega-3 (omega-3) fatty acid and omega-6 (omega-6) fatty acid is adjusted to 1:4 or less to obtain livestock products, such as meat or milk, containing a large amount of unsaturated fatty acid. More specifically, the present invention related to a feed composition using perilla meal to produce livestock products with the ratio of omega-3 to omega-6 fatty acids being 1:4 or less which is a recommended ratio of the World Health Organization (WHO).

The invention relates to a homogeneous, solid, particulate, urea ammonium sulphate (UAS)-based composition comprising urea ammonium sulphate, a urease inhibitor of the type phosphoric triamide and magnesium sulphate, characterized in that the UAS-based composition comprises 0.02 to 1 weight % of magnesium sulphate, 0.0001 to 1 weight % of the urease inhibitor and about 5 to about 30 weight % of ammonium sulphate. The composition according to the invention has improved properties for reducing ammonia loss by urease activity in the soil and is in particular suitable as a fertilizer. The invention further relates to a method for the manufacture of a homogeneous, solid, particulate urea ammonium sulphate-based composition comprising urea, ammonium sulphate and a urease inhibitor of the type phosphoric triamide, in particular N-(n-butyl) thiophosphoric triamide (nBTPT), as well as to a composition of kit of parts comprising an amount of a) magnesium sulphate; b) a urease inhibitor of the type phosphoric triamide, preferably N-(n-butyl) thiophosphoric triamide (nBTPT); c) optionally, an alkaline or alkaline-forming compound, selected from the group of calcium oxide, zinc oxide, magnesium oxide, calcium carbonate, and mixtures thereof, and d) optionally, one or more anti-caking and/or moisture-repellent and/or anti-dust compounds.

The present invention is concerned with boosting innate immunity in animals with an immune system that includes an alternative complement pathway in which they are fed an effective amount of a red seaweed of Asparagopsis species.